Zy Therapeutics, LLC is a rare disease biotech developing the first therapy to directly target brain calcifications, an overlooked driver of seizures, cognitive decline, and disability in rare CNS disorders. Our work is guided by both professional experience and personal connections to the conditions we aim to treat.
Zy represents a revolutionary step forward in the creation of lean biopharmaceuticals that develop life-saving medications in shorter amounts of time and at a fraction of traditional costs
By improving brain delivery of a proven safe molecule, we aim to deliver the first disease-modifying treatment for these devastating conditions.
Our mission is simple: Transform brain calcification into a treatable target and bring hope to patients and families living with rare CNS disorders.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.